A Linear Trinuclear Oxidodiperoxido-molybdenum(VI) Complex with Single Triazole Bridges: Catalytic Activity in Epoxidation, Alcoholysis, and Acetalization Reactions

Ultrasound Assisted Synthesis and In Silico Modelling of 1,2,4-Triazole Coupled Acetamide Derivatives of 2-(4-Isobutyl phenyl)propanoic acid as Potential Anticancer Agents

The development of an economical method for the synthesis of biologically active compounds was the major goal of this research. In the present study, we have reported the ultrasound-radiation-assisted synthesis of a series of novel N-substituted 1,2,4-triazole-2-thiol derivatives. The target compounds 6a−f were efficiently synthesized in significant yields (75−89%) by coupling 1,2,4-triazole of 2-(4-isobutylphenyl) propanoic acid 1 with different electrophiles using ultrasound radiation under different temperatures. The sonication process accelerated the rate of the reaction as well as yielded all derivatives compared to conventional methods. All derivatives were confirmed by spectroscopic (FTIR, 1HNMR, 13CNMR, HRMS) and physiochemical methods. All derivatives were further screened for their anticancer effects against the HepG2 cell line. Compound 6d containing two electron-donating methyl moieties demonstrated the most significant anti-proliferative activity with an IC50 value of 13.004 µg/mL, while compound 6e showed the lowest potency with an IC50 value of 28.399 µg/mL. The order of anticancer activity was found to be: 6d > 6b > 6f > 6a > 6c > 6e, respectively. The in silico modelling of all derivatives was performed against five different protein targets and the results were consistent with the biological activities. Ligand 6d showed the best binding affinity with the Protein Kinase B (Akt) pocket with the lowest ∆G value of −176.152 kcal/mol. Compound 6d has been identified as a promising candidate for treatment of liver cancer.

Green solvent free epoxidation of olefins by a heterogenised hydrazone-dioxidotungsten(vi) coordination compound

A new mononuclear tungsten coordination compound, [WO₂L(CH₃OH)] (1), was synthesized by the reaction of WCl₆ and H₂L (H₂L = (E)-4-amino-N′-(5-bromo-2-hydroxybenzylidene)benzohydrazide) in methanol. Both the H₂L and compound 1 were characterized by elemental analysis and UV-Vis, FT-IR and NMR spectroscopic methods. The molecular structure of compound 1 was also determined by single crystal X-ray analysis which confirmed the compound is a mononuclear coordination compound of cis-dioxidotungsten(vi) containing a free amine functionality on the ligand. Compound 1 was supported on propionyl chloride-functionalized silica gel by amidification reaction to obtain a heterogeneous catalyst. The obtained heterogeneous catalyst was characterized by FT-IR spectroscopy, thermal gravimetric analysis (TGA), diffuse-reflectance spectroscopy (DRS), X-ray diffraction analysis (XRD), energy-dispersive X-ray spectroscopy (EDX), X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) and its catalytic activity was investigated in the epoxidation of olefins with hydrogen peroxide under solvent free conditions. The catalyst was successfully recovered several times and the recovered catalyst was also characterized by various methods including FT-IR, DRS, TGA, SEM and EDX analyses. The results indicated this heterogeneous catalytic system is an effective and selective catalyst for epoxidation of olefins and can be reused several times without significant change in its catalytic activity.

In this study the solvent free catalytic oxidation of olefins by a new silica supported hydrazone-dioxidotungsten(vi) coordination compound is investigated.

Synthesis and biological evaluation of heterocyclic 1,2,4-triazole scaffolds as promising pharmacological agents

Background

Triazole is an important heterocyclic moiety that occupies a unique position in heterocyclic chemistry, due to its large number of biological activities. It exists in two isomeric forms i.e. 1,2,4-triazole and 1,2,3-triazole and is used as core molecule for the design and synthesis of many medicinal compounds. 1,2,4-Triazole possess broad spectrum of therapeutically interesting drug candidates such as analgesic, antiseptic, antimicrobial, antioxidant, anti-urease, anti-inflammatory, diuretics, anticancer, anticonvulsant, antidiabetic and antimigraine agents.

Methods

The structures of all synthesized compounds were characterized by physicochemical properties and spectral means (IR and NMR). The synthesized compounds were evaluated for their in vitro antimicrobial activity against Gram-positive (B. subtilis), Gram-negative (P. aeruginosa and E. coli) bacterial and fungal (C. albicans and A. niger) strains by tube dilution method using ciprofloxacin, amoxicillin and fluconazole as standards. In-vitro antioxidant and anti-urease screening was done by DPPH assay and indophenol method, respectively. The in-vitro anticancer evaluation was carried out against MCF-7 and HCT116 cancer cell lines using 5-FU as standards.

Results, discussion and conclusion

The biological screening results reveal that the compounds T₅ (MIC_{BS, EC} = 24.7 µM, MIC_PA, _CA = 12.3 µM) and T₁₇ (MIC_AN = 27.1 µM) exhibited potent antimicrobial activity as comparable to standards ciprofloxacin, amoxicillin (MIC_Cipro = 18.1 µM, MIC_Amo = 17.1 µM) and fluconazole (MIC_Flu = 20.4 µM), respectively. The antioxidant evaluation showed that compounds T₂ (IC₅₀ = 34.83 µg/ml) and T₃ (IC₅₀ = 34.38 µg/ml) showed significant antioxidant activity and comparable to ascorbic acid (IC₅₀ = 35.44 µg/ml). Compounds T₃ (IC₅₀ = 54.01 µg/ml) was the most potent urease inhibitor amongst the synthesized compounds and compared to standard thiourea (IC₅₀ = 54.25 µg/ml). The most potent anticancer activity was shown by compounds T₂ (IC₅₀ = 3.84 μM) and T₇ (IC₅₀ = 3.25 μM) against HCT116 cell lines as compared to standard 5-FU (IC₅₀ = 25.36 μM).

A new approach to the mechanism for the acetalization of benzaldehyde over MOF catalysts

The benzaldehyde acetalization catalyzed by UiO-66 and UiO-66F, was carried out in a batch-type reactor at room temperature and atmospheric pressure, and the full kinetic study was performed using the Langmuir–Hinshelwood and Eley–Rideal models.

Recent Progress in Application of Molybdenum-Based Catalysts for Epoxidation of Alkenes

Epoxides are important industrial intermediates applied in a variety of industrial processes. During the production of epoxides, catalysts have played an irreplaceable and unique role. In this review, the historic progress of molybdenum-based catalysts in alkene epoxidation are covered and an outlook on future challenge discussed. Efficient catalysts are demonstrated including soluble molybdenum complexes, polyoxometalates catalysts, molybdenum-containing metal organic frameworks, silica supported molybdenum-based catalysts, polymer supported molybdenum-based catalysts, magnetic molybdenum-based catalysts, hierarchical molybdenum-based catalysts, graphene-based molybdenum containing catalysts, photocatalyzed epoxidation catalysts, and some other systems. The effects of different solvents and oxidants are discussed and the mechanisms of epoxidation are summarized. The challenges and perspectives to further enhance the catalytic performances in alkenes epoxidation are presented.